1 Min Read
Sept 19 (Reuters) - Novavax Inc
* Novavax initiates phase 1/2 trial of Nanoflu vaccine in older adults
* Novavax Inc - data from phase 1/2 trial of Nanoflu expected by end of 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.